Feb 29, 2016

Posted by in Stock Reports | 0 Comments

It’s Never Too Late: Trading on Stock Upgrades: Continental Resources Inc (NYSE:CLR), Keryx Biopharmaceuticals Inc (NASDAQ:KERX), U.S. Silica Holdings Inc (NYSE:SLCA)

It’s Never Too Late: Trading on Stock Upgrades: Continental Resources Inc (NYSE:CLR), Keryx Biopharmaceuticals Inc (NASDAQ:KERX), U.S. Silica Holdings Inc (NYSE:SLCA)

Analysts have been actively evaluating companies as long as there have been stocks, but they’re more popular and get more exposure than ever thanks to round-the-clock stock market news and online resources. Analysts’ notoriety has also increased. But while analysts typically have similar credentials, they aren’t all the same.

The reputation and credibility of a company and the research firm depends on the efforts they make to inform investors. A company does not want to be tarnished by being associated with disreputable research. Similarly, a research firm will only want to analyze companies that have strong fundamentals and long-term investment potential.

Scotia Howard Weil upgraded Continental Resources Inc (NYSE:CLR) to Focus Stock from Sector Outperform on Friday. The stock has a consensus Buy rating, according to Zacks Investment Research. No analyst has rated the stock with a sell rating, 6 have assigned a hold rating, 4 say it’s a buy, and 7 have assigned a strong buy rating to the company.

In a note to investors, Raymond James upgraded Keryx Biopharmaceuticals Inc (NASDAQ:KERX) to Outperform from Mkt Perform. It has earned a consensus Strong Buy rating, according to Zacks Investment Research. No analyst has rated the stock with a sell rating, 4 have assigned a hold rating, Zero says it’s a buy and 5 have assigned a strong buy rating to the company.

According to a research note released on Friday, Jefferies has upgraded U.S. Silica Holdings Inc (NYSE:SLCA) from Underperform to Hold. The average analysts that follow this company have a ‘Strong Buy’ rating, according to Zacks Investment Research. Among analysts covering the stock, 9 maintain strong buy rating, 1 set the stock as buy, 1 give underperform rating and Zero suggests selling.

 

Comments are closed.